Regional variation in histopathology‐specific incidence of invasive cervical cancer among Peruvian women
dc.contributor.author | Pierce Campbell, Christine M. | |
dc.contributor.author | Curado, Maria P. | |
dc.contributor.author | Harlow, Siobán D. | |
dc.contributor.author | Soliman, Amr S. | |
dc.date.accessioned | 2017-01-10T19:10:31Z | |
dc.date.available | 2017-01-10T19:10:31Z | |
dc.date.issued | 2012-01 | |
dc.identifier.citation | Pierce Campbell, Christine M.; Curado, Maria P.; Harlow, Siobán D. ; Soliman, Amr S. (2012). "Regional variation in histopathology‐specific incidence of invasive cervical cancer among Peruvian women." International Journal of Gynecology & Obstetrics 116(1): 47-51. | |
dc.identifier.issn | 0020-7292 | |
dc.identifier.issn | 1879-3479 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/135622 | |
dc.description.abstract | ObjectiveTo evaluate patterns of cervical cancer incidence in Peru by examining variation in 2 common histopathologic types, squamous cell carcinoma (SCC) and adenocarcinoma (ADC), and analyzing trends over time.MethodsData on the incidence of invasive cervical cancer between 1984 and 2006 were obtained from 3 population‐based cancer registries in Peru: Lima, Trujillo, and Arequipa. For each registry, data quality assessment was performed, crude and age‐specific incidence was calculated, and time trends were analyzed.ResultsOverall and SCC incidence varied across registries but incidence of ADC did not. Overall and SCC incidence showed significant declines in Trujillo (P < 0.05) and modest declines in Lima (P > 0.05) over time. ADC incidence showed marginally significant increases among women aged 15–29 years in Trujillo (P = 0.10) and modest increases among young women in Lima (P > 0.05).ConclusionPopulation‐based cancer registries were an efficient source of data for evaluating the incidence of cervical cancer once data quality had been established. Geographic and temporal variations in cervical cancer burden were documented in Peru. The trends suggest that cervical ADC is increasing among young women in urban Peru, particularly in Trujillo. We recommend supplementing current Papanicolaou test screening with complementary methods of cervical cancer control, including human papillomavirus (HPV) vaccination and HPV DNA testing. | |
dc.publisher | IARC Press | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | Incidence | |
dc.subject.other | Peru | |
dc.subject.other | Cervical cancer | |
dc.subject.other | Histopathology | |
dc.subject.other | Epidemiology | |
dc.title | Regional variation in histopathology‐specific incidence of invasive cervical cancer among Peruvian women | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.contributor.affiliationum | Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, USA | |
dc.contributor.affiliationother | Cancer Information Section, International Agency for Research on Cancer, Lyon, France | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/135622/1/ijgo47.pdf | |
dc.identifier.doi | 10.1016/j.ijgo.2011.08.008 | |
dc.identifier.source | International Journal of Gynecology & Obstetrics | |
dc.identifier.citedreference | Almonte M., Albero G., Molano M., Carcamo C., García P.J., Pérez G., Risk factors for human papillomavirus exposure and co‐factors for cervical cancer in Latin America and the Caribbean. Vaccine. 26 ( Suppl. 11 ): 2008; L16 – L36 | |
dc.identifier.citedreference | Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer J Clin. 61 ( 2 ): 2011; 69 – 90 | |
dc.identifier.citedreference | Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127 ( 12 ): 2010; 2893 – 2917 | |
dc.identifier.citedreference | Boyle P., Levin B., World Cancer Report 2008. 2008; IARC Press: Lyon, France; 288 – 290 | |
dc.identifier.citedreference | Vizcaino A.P., Moreno V., Bosch F.X., Muñoz N., Barros‐Dios X.M., Borras J., et al. International trends in incidence of cervical cancer: II. Squamous‐cell carcinoma. Int J Cancer. 86 ( 3 ): 2000; 429 – 435 | |
dc.identifier.citedreference | Vizcaino A.P., Moreno V., Bosch F.X., Muñoz N., Barros‐Dios X.M., Parkin D.M., International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer. 75 ( 4 ): 1998; 536 – 545 | |
dc.identifier.citedreference | International Agency for Research on Cancer. Cancer Incidence in Five Continents Vol. IX. www.iarc.fr. http://www.iarc.fr/en/publications/pdfs‐online/epi/sp160/index.php. Published 2007 | |
dc.identifier.citedreference | Castellsagué X., Díaz M., de Sanjosé S., Muñoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 98 ( 5 ): 2006; 303 – 315 | |
dc.identifier.citedreference | Muñoz N., Franco E.L., Herrero R., Andrus J.K., de Quadros C., Goldie S.J., et al. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine. 26 ( Suppl. 11 ): 2008; L96 – L107 | |
dc.identifier.citedreference | Murillo R., Almonte M., Pereira A., Ferrer E., Gamboa O.A., Jerónimo J., et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine. 26 ( Suppl. 11 ): 2008; L37 – L48 | |
dc.identifier.citedreference | Sankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., et al. HPV screening for cervical cancer in rural India. N Engl J Med. 360 ( 14 ): 2009; 1385 – 1394 | |
dc.identifier.citedreference | Daly L., Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med. 22 ( 5 ): 1992; 351 – 361 | |
dc.identifier.citedreference | Powell J., Data sources and reporting. Jensen O.M., Parkin D.M., MacLennan R., Muir C.S., Skeet R.G.. Cancer Registration: Principles and Methods. IARC Scientific Publications No. 95. 1991; IARC Press: Lyon, France; 35 | |
dc.identifier.citedreference | An H.J., Kim K.R., Kim I.S., Kim D.W., Park M.H., Park I.A., et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population‐based study. Mod Pathol. 18 ( 4 ): 2005; 528 – 534 | |
dc.identifier.citedreference | International Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 120 ( 4 ): 2007; 885 – 891 | |
dc.identifier.citedreference | Smith H.O., Tiffany M.F., Qualls C.R., Key C.R., The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24‐year population‐based study. Gynecol Oncol. 78 ( 2 ): 2000; 97 – 105 | |
dc.identifier.citedreference | Liu S., Semenciw R., Probert A., Mao Y., Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer. 11 ( 1 ): 2001; 24 – 31 | |
dc.identifier.citedreference | Bray F., Carstensen B., Møller H., Zappa M., Zakelj M.P., Lawrence G., et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 14 ( 9 ): 2005; 2191 – 2199 | |
dc.identifier.citedreference | Martins E., Curado M.P., Freitas N.M., de Oliveira J.C., Freitas R. Jr.. Increase in cervical adenocarcinoma rate in Goiânia, GO, Brazil. Int J Gynecol Cancer. 19 ( 4 ): 2009; 694 – 698 | |
dc.identifier.citedreference | Krane J.F., Granter S.R., Trask C.E., Hogan C.L., Lee K.R., Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer. 93 ( 1 ): 2001; 8 – 15 | |
dc.identifier.citedreference | Raab S.S., Can glandular lesions be diagnosed in pap smear cytology?. Diagn Cytopathol. 23 ( 2 ): 2000; 127 – 133 | |
dc.identifier.citedreference | Parkin D.M., Bray F., Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer. 45 ( 5 ): 2009; 756 – 764 | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.